Creating accessible care options for patients—from their own homes.
PRA’s Mobile Health Platform (MHP) engages with patients wherever they are. Our app-based platform allows us to do everything that’s possible in a physician’s office or clinical site, virtually.
The same way you bank, sign documents, email, and text on your phone—we can do all of that within a mobile environment for your trial.
Mobile solutions to meet your unique needs.
Today, we have the ability to educate patients, gather electronic informed consent and e-signatures, and complete patient reported outcomes—right from the patient’s phone. Using connected devices, we can collect home healthcare data in the same mobile app and serve all of that data into the source for the clinical trial.
Reducing the burden of participation for patients.
The traditional approach to clinical development requires 100% of visits to take place on-site, which places a huge burden on patients. We have the resources to change that.
If we can enable patients to complete 50% to 75% of clinical tasks in their mobile environment before arriving on-site, that site visit might only last an hour instead of five. It may seem small, but those four hours can have a meaningful impact for patients and site staff.
Our digital health solutions are built with each specific trial in mind. Depending on the disease state, the patient population, and our sponsor’s targets, our experts will help determine what is most applicable to your particular trial. From enrollment and ongoing engagement efforts to consultations and in-depth analysis, we have the tools needed to conduct your hybrid or virtual trial from start to finish.
Read about PRA’s role in the first-ever, fully virtual clinical trial.
We identify ways to minimize time on-site, often replacing site visits with home healthcare visits and even full virtual visits—while still collecting necessary endpoints in a valid way. By incorporating mobile solutions, we can reduce the burden on patients and provide significant value to our sponsors.
Learn how wearable technologies are eliminating many traditional barriers of clinical trial participation.You may also be interested in:
Case Study
Innovative Technology Solution for a 15 Year Rare Disease Gene Therapy Registry
A Top 10 pharmaceutical client required a mobile technology solution to collect safety and effectiveness data on a groundbreaking treatment for an…
blog
PRA leverages remote patient monitoring strategies to mitigate risk, improve safety during COVID-19 outbreak
The impact of COVID-19 (Coronavirus) is being felt across the globe with a tremendous amount of confusing information and rapidly changing medical…
Blog
Janssen Pharmaceuticals and PRA Health Sciences Launch First Fully Virtual Trial for Heart Failure Drug Approval
Janssen Pharmaceuticals and PRA Health Launch First Fully Virtual Trial for Heart Failure Drug Approval. Healthcare giant Janssen Pharmaceuticals and…